← Back
Data updated: Mar 10, 2026
ACERTIS PHARMS
Pharmaceuticals
ACERTIS PHARMS is a specialty pharmaceutical company with 4 FDA-approved products.
1977
Since
4
Drugs
-
Trials
22
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
PROMETRIUM 2026-02-12
Labeling
LEVORPHANOL TARTRATE 2025-12-22
Labeling
LEVORPHANOL TARTRATE 2025-12-22
Labeling
LEVORPHANOL TARTRATE 2025-12-22
Labeling
LEVORPHANOL TARTRATE 2025-12-22
Labeling
LEVORPHANOL TARTRATE 2025-12-22
Labeling
LEVORPHANOL TARTRATE 2025-12-22
Labeling
LEVORPHANOL TARTRATE 2025-12-22
Labeling
ALBUTEROL SULFATE 2025-12-01
ALBUTEROL SULFATE 2025-11-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (2)
Company Info
- First Approval
- 1977-08-19
- Latest
- 2026-02-12
- Applications
- 5